PL1761519T3 - Pochodne indolu jako antagoniści receptorów histaminowych - Google Patents
Pochodne indolu jako antagoniści receptorów histaminowychInfo
- Publication number
- PL1761519T3 PL1761519T3 PL05756581T PL05756581T PL1761519T3 PL 1761519 T3 PL1761519 T3 PL 1761519T3 PL 05756581 T PL05756581 T PL 05756581T PL 05756581 T PL05756581 T PL 05756581T PL 1761519 T3 PL1761519 T3 PL 1761519T3
- Authority
- PL
- Poland
- Prior art keywords
- receptor antagonists
- indole derivatives
- histamine receptor
- histamine
- indole
- Prior art date
Links
- 229940122236 Histamine receptor antagonist Drugs 0.000 title 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
- 150000002475 indoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04102839 | 2004-06-21 | ||
| EP05756581A EP1761519B1 (en) | 2004-06-21 | 2005-06-13 | Indole derivatives as histamine receptor antagonists |
| PCT/EP2005/006303 WO2005123716A1 (en) | 2004-06-21 | 2005-06-13 | Indole derivatives as histamine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1761519T3 true PL1761519T3 (pl) | 2008-09-30 |
Family
ID=34982342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05756581T PL1761519T3 (pl) | 2004-06-21 | 2005-06-13 | Pochodne indolu jako antagoniści receptorów histaminowych |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7361682B2 (pl) |
| EP (1) | EP1761519B1 (pl) |
| JP (1) | JP4652404B2 (pl) |
| CN (1) | CN1972926B (pl) |
| AR (1) | AR049696A1 (pl) |
| AT (1) | ATE394391T1 (pl) |
| AU (1) | AU2005254658B2 (pl) |
| BR (1) | BRPI0512335A (pl) |
| CA (1) | CA2569611C (pl) |
| DE (1) | DE602005006567D1 (pl) |
| DK (1) | DK1761519T3 (pl) |
| ES (1) | ES2306170T3 (pl) |
| IL (1) | IL179737A (pl) |
| MX (1) | MXPA06014810A (pl) |
| MY (1) | MY139941A (pl) |
| NO (1) | NO20070336L (pl) |
| NZ (1) | NZ551663A (pl) |
| PL (1) | PL1761519T3 (pl) |
| PT (1) | PT1761519E (pl) |
| RU (1) | RU2382778C2 (pl) |
| TW (1) | TW200612936A (pl) |
| WO (1) | WO2005123716A1 (pl) |
| ZA (1) | ZA200610416B (pl) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006077024A2 (en) | 2005-01-19 | 2006-07-27 | F. Hoffmann-La Roche Ag | 5-aminoindole derivatives |
| AU2006319234B2 (en) | 2005-11-30 | 2012-01-19 | F. Hoffmann-La Roche Ag | 1,5-substituted indol-2-yl amide derivatives |
| ES2342979T3 (es) * | 2005-11-30 | 2010-07-20 | F. Hoffmann-La Roche Ag | Derivados de indol-2-carboxamida sustituidos en 5. |
| EP1968967B1 (en) | 2005-11-30 | 2011-04-27 | F. Hoffmann-La Roche AG | 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators |
| WO2007115938A1 (en) | 2006-04-12 | 2007-10-18 | F. Hoffmann-La Roche Ag | 5-amido-2-carboxamide indoles |
| US7432255B2 (en) | 2006-05-16 | 2008-10-07 | Hoffmann-La Roche Inc. | 1H-indol-5-yl-piperazin-1-yl-methanone derivatives |
| US7514433B2 (en) * | 2006-08-03 | 2009-04-07 | Hoffmann-La Roche Inc. | 1H-indole-6-yl-piperazin-1-yl-methanone derivatives |
| PT2354124E (pt) | 2006-12-19 | 2013-04-09 | Hoffmann La Roche | Derivados de heteroaril-pirrolidinilo e piperidinil-cetona |
| ES2627221T3 (es) | 2006-12-28 | 2017-07-27 | Rigel Pharmaceuticals, Inc. | Compuestos de heterocicloalquiloxibenzamida N-sustituidos y métodos de uso |
| US7557108B2 (en) * | 2007-02-07 | 2009-07-07 | Hoffmann-La Roche Inc. | (Indol-4-yl) or (indol-5-yl)-piperazinylmethanones |
| US7648979B2 (en) * | 2007-02-07 | 2010-01-19 | Hoffmann-La Roche Inc. | 5-amido-(1H-indol-2-yl)-piperazin-1-yl-methanone derivatives |
| US7507736B2 (en) * | 2007-02-07 | 2009-03-24 | Hoffmann-La Roche Inc. | Indol-2-yl-piperazin-1-yl-methanone derivatives |
| US20110178062A1 (en) * | 2007-03-01 | 2011-07-21 | Allison Brett D | Indole and benzothiophene compounds as modulators of the histamine h3 receptor |
| AU2008280257A1 (en) * | 2007-07-25 | 2009-01-29 | F. Hoffmann-La Roche Ag | Benzofuran- and benzo[B]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators |
| AU2008292420A1 (en) * | 2007-08-31 | 2009-03-05 | Astellas Pharma Inc. | Piperidine derivative |
| ES2552733T3 (es) | 2007-11-16 | 2015-12-01 | Rigel Pharmaceuticals, Inc. | Compuestos de carboxamida, sulfonamida y amina para trastornos metabólicos |
| WO2009076631A1 (en) | 2007-12-12 | 2009-06-18 | Rigel Pharmaceuticals, Inc. | Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| EP2276761B1 (en) | 2008-04-23 | 2015-07-29 | Rigel Pharmaceuticals, Inc. | Carboxamide compounds for the treatment of metabolic disorders |
| WO2009158375A1 (en) * | 2008-06-25 | 2009-12-30 | Abbott Laboratories | Aza-cylic indole- 2 -carboxamides and methods of use thereof |
| FR2950053B1 (fr) * | 2009-09-11 | 2014-08-01 | Fournier Lab Sa | Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson |
| EP2888243B1 (en) * | 2012-08-23 | 2016-08-17 | Suven Life Sciences Limited | Acrylamide compounds as histamine h3 receptor ligands |
| EP2722329A1 (en) * | 2012-10-18 | 2014-04-23 | F. Hoffmann-La Roche AG | Indol-amide compounds as beta-amyloid inhbitors |
| KR101551313B1 (ko) * | 2014-07-28 | 2015-09-09 | 충남대학교산학협력단 | 신규한 인덴 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 망막 질환의 예방 또는 치료용 약학적 조성물 |
| CN106065008B (zh) * | 2016-06-16 | 2018-06-05 | 黑龙江中医药大学 | 一种具有改善睡眠作用的吲哚-2-酰胺类化合物及其应用 |
| CA3052480A1 (en) | 2017-02-17 | 2018-08-23 | Trevena, Inc. | 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same |
| EP3582783B1 (en) | 2017-02-17 | 2023-06-07 | Trevena, Inc. | 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2705095B1 (fr) * | 1993-05-12 | 1995-06-23 | Adir | Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| HU227568B1 (en) * | 1997-12-24 | 2011-08-29 | Sanofi Aventis Deutschland | Indole derivatives, as inhibitors os factor xa |
| EP0978512A1 (en) * | 1998-07-29 | 2000-02-09 | Societe Civile Bioprojet | Non-imidazole aryloxy (or arylthio) alkylamines as histamine H3-receptor antagonists and their therapeutic applications |
| AU2001247906A1 (en) * | 2000-03-31 | 2001-10-15 | Ortho-Mcneil Pharmaceutical, Inc. | Phenyl-substituted indoles and indazoles |
| HU227197B1 (en) * | 2000-10-24 | 2010-10-28 | Richter Gedeon Nyrt | Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them |
| US6803362B2 (en) * | 2001-03-09 | 2004-10-12 | Ortho-Mcneil Pharmaceutical Inc. | Heterocyclic compounds |
| US6673829B2 (en) * | 2001-09-14 | 2004-01-06 | Novo Nordisk A/S | Aminoazetidine,-pyrrolidine and -piperidine derivatives |
| JP4326468B2 (ja) * | 2002-06-24 | 2009-09-09 | シェーリング コーポレイション | ヒスタミンh3アンタゴニストとして有用なインドール誘導体 |
-
2005
- 2005-06-13 PL PL05756581T patent/PL1761519T3/pl unknown
- 2005-06-13 JP JP2007517135A patent/JP4652404B2/ja not_active Expired - Fee Related
- 2005-06-13 MX MXPA06014810A patent/MXPA06014810A/es active IP Right Grant
- 2005-06-13 PT PT05756581T patent/PT1761519E/pt unknown
- 2005-06-13 WO PCT/EP2005/006303 patent/WO2005123716A1/en not_active Ceased
- 2005-06-13 CN CN2005800204455A patent/CN1972926B/zh not_active Expired - Fee Related
- 2005-06-13 NZ NZ551663A patent/NZ551663A/en unknown
- 2005-06-13 BR BRPI0512335-6A patent/BRPI0512335A/pt not_active IP Right Cessation
- 2005-06-13 RU RU2007102224/04A patent/RU2382778C2/ru not_active IP Right Cessation
- 2005-06-13 EP EP05756581A patent/EP1761519B1/en not_active Expired - Lifetime
- 2005-06-13 AU AU2005254658A patent/AU2005254658B2/en not_active Ceased
- 2005-06-13 AT AT05756581T patent/ATE394391T1/de active
- 2005-06-13 DK DK05756581T patent/DK1761519T3/da active
- 2005-06-13 CA CA2569611A patent/CA2569611C/en not_active Expired - Fee Related
- 2005-06-13 ES ES05756581T patent/ES2306170T3/es not_active Expired - Lifetime
- 2005-06-13 DE DE602005006567T patent/DE602005006567D1/de not_active Expired - Lifetime
- 2005-06-17 AR ARP050102510A patent/AR049696A1/es not_active Application Discontinuation
- 2005-06-20 US US11/157,093 patent/US7361682B2/en not_active Expired - Fee Related
- 2005-06-20 TW TW094120464A patent/TW200612936A/zh unknown
- 2005-06-20 MY MYPI20052800A patent/MY139941A/en unknown
-
2006
- 2006-11-30 IL IL179737A patent/IL179737A/en not_active IP Right Cessation
- 2006-12-12 ZA ZA200610416A patent/ZA200610416B/xx unknown
-
2007
- 2007-01-18 NO NO20070336A patent/NO20070336L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2382778C2 (ru) | 2010-02-27 |
| NO20070336L (no) | 2007-02-13 |
| IL179737A0 (en) | 2007-05-15 |
| NZ551663A (en) | 2009-09-25 |
| BRPI0512335A (pt) | 2008-03-04 |
| CA2569611A1 (en) | 2005-12-29 |
| JP4652404B2 (ja) | 2011-03-16 |
| AU2005254658B2 (en) | 2011-06-16 |
| ES2306170T3 (es) | 2008-11-01 |
| US20050282864A1 (en) | 2005-12-22 |
| TW200612936A (en) | 2006-05-01 |
| JP2008503511A (ja) | 2008-02-07 |
| DK1761519T3 (da) | 2008-07-21 |
| CA2569611C (en) | 2012-12-11 |
| EP1761519A1 (en) | 2007-03-14 |
| CN1972926B (zh) | 2011-02-16 |
| MY139941A (en) | 2009-11-30 |
| PT1761519E (pt) | 2008-07-02 |
| RU2007102224A (ru) | 2008-07-27 |
| DE602005006567D1 (de) | 2008-06-19 |
| EP1761519B1 (en) | 2008-05-07 |
| MXPA06014810A (es) | 2007-02-12 |
| CN1972926A (zh) | 2007-05-30 |
| US7361682B2 (en) | 2008-04-22 |
| AU2005254658A1 (en) | 2005-12-29 |
| IL179737A (en) | 2011-12-29 |
| AR049696A1 (es) | 2006-08-30 |
| WO2005123716A1 (en) | 2005-12-29 |
| ZA200610416B (en) | 2008-09-25 |
| ATE394391T1 (de) | 2008-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL179737A0 (en) | Indole derivatives as histamine receptor antagonists | |
| ZA200800320B (en) | Indol-3-carbonyl-spiro-piperidine derivatives as Via receptor antagonists | |
| ZA200700683B (en) | Piperidine derivatives as histamine H3 receptor ligands | |
| IL165863A0 (en) | Indole derivatives useful as histamine H3 antagonists | |
| ZA200705085B (en) | 2,3,4,9-Tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists | |
| ZA200801432B (en) | Carboxamide derivatives as muscarinic receptor antagonists | |
| SI1636206T1 (sl) | Imidazolni derivati kot antagonisti receptorja glutamata | |
| AP2006003840A0 (en) | Indole-2-carboxamidine derivatives as NMDA receptor antagonists | |
| TWI348466B (en) | Novel diketopiperazine derivatives as oxytocin receptor antagonists | |
| IL178622A0 (en) | Piperazinylpiperidine derivatives as chemokine receptor antagonists | |
| ZA200802339B (en) | Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists | |
| PT1912976E (pt) | Derivados de indol-3-il-carboni-piperidin-benzimidazole como antagonistas dos receptores v1a | |
| HU0501169D0 (en) | New phenantridine derivatives as selective bradykinin b1 receptor antagonists | |
| IL179518A0 (en) | Mercaptoimidazoles as ccr2 receptor antagonists | |
| ZA200608369B (en) | Piperazinylpiperidine derivatives as chemokine receptor antagonists | |
| ZA200800516B (en) | Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as V1a receptor antagonists | |
| HK1144427A (en) | Oxypiperidine derivatives as histamine receptor antagonists | |
| HK1114378A (en) | 5-ht7 receptor antagonists | |
| HK1113135A (en) | 5-ht7 receptor antagonists | |
| HK1106517A (en) | 5-ht7 receptor antagonists | |
| HK1105410A (en) | 5-ht7 receptor antagonists | |
| SI1539742T1 (sl) | Indolni derivati, uporabni kot antagonisti histamina H3 | |
| GB0408062D0 (en) | 5-HT2B receptor antagonists | |
| GB0408063D0 (en) | 5-HT2B receptor antagonists | |
| GB0408064D0 (en) | 5-HT2B receptor antagonists |